Purple Biotech (PPBT) Current Assets (2014 - 2026)
Purple Biotech (PPBT) reported Current Assets of $6.8 million for Q1 2026, down 31.29% on a QoQ basis from $9.9 million in Q4 2025.
Purple Biotech (PPBT) has 11 years of Current Assets data on file, last reported at $6.8 million in Q1 2026.
- Quarterly Current Assets changed N/A year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (changed N/A YoY) and the FY2025 annual result came in at $9.9 million, up 10.75% from the prior year.
- Current Assets retreated to $6.8 million in Q1 2026 per PPBT's latest filing, from $9.9 million in the prior quarter.
- Across five years, Current Assets topped out at $33.3 million in Q4 2022 and bottomed at $6.8 million in Q1 2026.
- The 5-year median for Current Assets is $9.9 million (2025), against an average of $14.9 million.
- The widest annual swing landed in 2023, when Current Assets tumbled 52.53%; it then grew 10.75% in 2025.
- Tracing PPBT's Current Assets over 5 years: stood at $33.3 million in 2022, then plunged by 52.53% to $15.8 million in 2023, then plunged by 43.58% to $8.9 million in 2024, then increased by 10.75% to $9.9 million in 2025, then tumbled by 31.29% to $6.8 million in 2026.
- Per Business Quant, the three latest PPBT Current Assets figures stand at $6.8 million (Q1 2026), $9.9 million (Q4 2025), and $8.9 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 6.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.78 Mn |
| Dec 31, 2025 | 9.87 Mn |
| Sep 30, 2025 | 10.77 Mn |
| Jun 30, 2025 | 6.31 Mn |
| Mar 31, 2025 | 7.52 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Sep 30, 2024 | 6.94 Mn |
| Jun 30, 2024 | 7.86 Mn |
| Mar 31, 2024 | 11.40 Mn |
| Dec 31, 2023 | 15.79 Mn |
| Sep 30, 2023 | 16.72 Mn |
| Jun 30, 2023 | 19.38 Mn |
| Mar 31, 2023 | 24.41 Mn |
| Dec 31, 2022 | 33.26 Mn |
| Sep 30, 2022 | 34.31 Mn |
| Jun 30, 2022 | 37.45 Mn |
| Mar 31, 2022 | 41.90 Mn |
| Dec 31, 2021 | 48.47 Mn |
| Sep 30, 2021 | 47.20 Mn |
| Jun 30, 2021 | 50.00 Mn |
| Mar 31, 2021 | 57.44 Mn |
| Dec 31, 2020 | 59.28 Mn |
| Jun 30, 2020 | 65.16 Mn |
| Dec 31, 2019 | 8.30 Mn |
| Jun 30, 2019 | 10.67 Mn |
| Dec 31, 2018 | 8.51 Mn |
| Jun 30, 2018 | 12.17 Mn |
| Dec 31, 2017 | 7.98 Mn |
| Jun 30, 2017 | 8.89 Mn |
| Dec 31, 2016 | 14.90 Mn |
| Jun 30, 2016 | 9.08 Mn |
| Dec 31, 2015 | 10.80 Mn |
| Sep 30, 2015 | 1.53 Mn |
| Dec 31, 2014 | 1.76 Mn |
| Sep 30, 2014 | 2.87 Mn |